Ideas
Futures selling masks cash accumulation
Foreigners are selling futures but buying cash, which suggests they are trying to buy spot cheaper rather than abandon the market; the trend remains strong and dips should be ridden.
Buy Hyundai robot value chain dips
Hyundai Motor Group's robot and autonomous-driving value chain is re-rating; Hyundai Motor will make robots and learn AI, Hyundai Mobis supplies parts, Hyundai AutoEver oversees software and autonomous driving with potential NVIDIA collaboration, and Hyundai Glovis owns a Boston Dynamics stake and can handle robot distribution. Buy the core trio on corrections.
Buy Samsung on earnings dip
Samsung Electronics should be bought if fourth-quarter earnings disappoint; Q4 memory contract prices rose 40-70%, the first quarter should improve, and HBM4 can add further valuation support.
SK hynix remains core memory holding
A practical portfolio should hold 50% Samsung Electronics and SK hynix, 20% biotech, and 10-20% Hyundai Motor Group, leaving the rest for trading or entertainment.
Olix targets fat without muscle loss
Olix's ALK7 fat-cell breakdown approach could separate fat loss from muscle loss, and its JP Morgan Healthcare disclosure is a catalyst for the obesity-treatment space.
Hanmi obesity drug limits muscle loss
Hanmi Pharm is pursuing an obesity treatment that limits muscle loss, and Korean drugmakers are finding attractive niche positions in the obesity market.
Ildong oral obesity data catalyst
Ildong Pharm rose because its oral obesity treatment is expected to be presented at JP Morgan Healthcare, giving it an event-driven catalyst.
HanAll pipeline and M&A potential
HanAll Biopharma may benefit as Roivant/Immunovant participates in a rights issue and prioritizes pipeline commercialization, including faster development of batoclimab; potential M&A could also lift value.
US Navy MRO license near
HJ Heavy Industries passed a final gate for a US Navy ship maintenance agreement and may obtain a license this month, opening it to large Pacific Fleet MRO work as aging US ships need repairs.
Focus top Korean biotech names
The Korean biotech rally is narrow, so investors should focus on top market-cap names and frequently discussed stocks or top-10 biotech ETFs rather than broad small-cap biotech.
Doosan Enerbility gas-turbine orders accelerate
Doosan Enerbility should be bought as credit and warning issues clear, gas-turbine orders accelerate, and it is one of the few suppliers that can deliver turbines within a year amid Japan-China rare-earth tensions.
HYBE resilient on BTS March
HYBE is less exposed to China and BTS activity in March should keep it more resilient; buy on sharp pullbacks.
Korea-China thaw helps entertainment
A revived Korea-China cultural exchange, including talk of a Korean-Chinese song festival, would benefit Korean entertainment stocks.
Shipbuilding defense nuclear to rally
Shipbuilding and defense are showing unusual strength and may rally again, while nuclear power should also move higher, so these sectors should be revisited.
Hanmi Semiconductor leads HBM equipment
Hanmi Semiconductor is the strongest semiconductor-equipment name, benefiting from HBM equipment demand and Samsung orders, with value-up moves as an added positive.
Rotate chip profits to dividend value
Investors who have large semiconductor gains should take some profits and rotate into dividend/value names such as SK Inc, CJ, LS, KB Financial, and Mirae Asset Securities as insurance.
POSCO Future M L&F rebound
POSCO Future M and L&F are not bad after heavy declines; both are in rebound trends and could offer 20-30% upside.
Samsung P5 drives equipment orders
Samsung's P5 project is driving equipment orders, while SK hynix equipment orders are limited until the Yongin cluster is clarified; focus on Samsung-linked equipment.
Buy SPG dips and HVM
SPG is a robot reducer supplier to buy on a 15%+ correction, while HVM is the core special-steel pick with plant expansion, nickel/iron alloy supply to SpaceX through SPG, and doubled SpaceX-related sales expected.
NAVER benefits from de-Coupang
NAVER is a beneficiary of the de-Coupang shift, with AI as an additional option.
RFHIC telecom defense optical cycle
RFHIC should benefit from a 2026-2030 telecom equipment big cycle, US market demand, defense issues, and its RF Materials unit's optical fiber substitution for Chinese products.
Buy WSI on pullbacks
WSI is expected to begin generating sales soon and has continuing issues, but investors should avoid chasing and instead buy on dips or near the close; earnings remain far below what revenue should support.
Micron memory shortage lifts earnings
Micron should benefit because HBM and DRAM shortages are extending the cycle, UBS raised its target to $400, and earnings power is understated; the recent pause is not a breakdown.
Intel AI PC pressures AMD
Intel's new AI PC chip launch lifted its shares and creates a competitive burden for AMD, making Intel the near-term relative winner.
Intel AI PC pressures AMD
Intel's new AI PC chip launch lifted its shares and creates a competitive burden for AMD, making Intel the near-term relative winner.
Tesla pullback may become buy
Tesla's weakness is a materials-lacking pullback after Q4 delivery concerns and NVIDIA autonomous competition, but large-cap selloffs can become low-buy opportunities after two or three waves.
Eli Lilly obesity leadership intact
Eli Lilly is regaining leadership in obesity and oral GLP-1 treatments, aided by M&A, and its strength supports Korean obesity-related suppliers.
Korean obesity names have catalysts
Olix, ABL Bio, and D&D Pharmatech have materials despite the market's chip focus, with JP Morgan Healthcare as a near-term catalyst.
Google gains on Gemini momentum
Google is benefiting from Gemini traffic-share gains, active-user growth, and its rise to second-largest market cap, so the stock remains positive.
Prefer KOSPI large caps over KOSDAQ
Money is concentrated in Samsung, SK hynix, Hyundai, and SK, so KOSPI large caps remain preferred over KOSDAQ unless government activation measures produce real results.
Prefer KOSPI large caps over KOSDAQ
Money is concentrated in Samsung, SK hynix, Hyundai, and SK, so KOSPI large caps remain preferred over KOSDAQ unless government activation measures produce real results.
Qualcomm 2nm can re-rate Samsung
Samsung's 20 trillion won operating profit is around consensus and the market wants more; if sell-on-news hits, Samsung should be bought, but semiconductor-equipment names may see more profit-taking.
Qualcomm validates Samsung foundry recovery
Fourth-quarter consensus is around 19-20 trillion won, but 2026 first-quarter estimates of 43-44 trillion won for Samsung and 44 trillion won for SK hynix show a steep memory upcycle and target-price upside.
Watch H200 China export approval
NVIDIA's H200 China export approval is a key watch item; approval and February shipments are expected, but China's request to halt orders introduces downside risk if it becomes binding.
Lilly M&A supports biotech momentum
Eli Lilly's $1.2 billion acquisition of Ventyx Biosciences expands its oral inflammatory and obesity footprint, and continued big-pharma M&A supports biotech momentum into JP Morgan Healthcare.
Korean obesity names eye JP Morgan
Korean obesity-related names such as Hanmi Pharm, D&D Pharmatech, Ildong Pharm, Olix, and ABL Bio are attracting expectations ahead of JP Morgan Healthcare and possible technology transfers or M&A.
Geopolitics supports defense stocks
Geopolitical tension from the US seizure of a Russian tanker and Trump's proposed $1.5 trillion defense budget support defense stocks, with European defense ETFs already rising.
Korea nuclear construction likely proceeds
The Korean government is expected to proceed with two new nuclear plants and will run a public survey in January, easing fears of cancellation and helping nuclear-related stocks.
Hyundai robot theme still strong
Hyundai Motor Group stocks are surging because CES and NVIDIA have refueled the robot and autonomous-driving theme; Hyundai Glovis, Hyundai AutoEver, Hyundai Wia, Yujin Robot, Hyundai Mobis, and HL Mando are key expressions.
Korean defense breaks to highs
Korean defense stocks are breaking to new highs, led by Korea Aerospace Industries, as global defense spending and geopolitics support the sector.
Space theme runs to SpaceX IPO
The space/aerospace theme should retain momentum until the SpaceX IPO, keeping related stocks in focus.
NVIDIA expands autonomous driving market
NVIDIA's push into autonomous driving can expand the market to legacy automakers, creating replacement demand similar to the smartphone shift; Hyundai AutoEver is viewed as the best Korean name.
Korea Fuel-Tech low debt hybrid
A hybrid-related auto-parts name, likely Korea Fuel-Tech, is attractive because it has low debt versus peers, a small market cap, and room to grow as auto-parts valuations re-rate.
Hanmi Semiconductor buy on pullback
Hanmi Semiconductor is resting before another new high as HBM equipment demand remains strong; it is a short-term attack point on a pullback to the 5-day line or around KRW 174,000.
Celltrion breaks two-year box
Celltrion broke out of a two-year box on CDMO and biosimilar momentum, US production, and foreign/institutional buying, with JP Morgan Healthcare as a near-term support; buy on pullbacks.
Samsung rebalancing selling is technical
Samsung's 20 trillion won profit was not a major surprise, and institutional selling is driven by portfolio rebalancing rather than weak fundamentals; if the stock keeps rising, institutions may be forced to chase, and sell-on-news should be bought.
Healthcare likely rotation destination
If semiconductor money is trimmed, healthcare/biotech is a likely rotation destination given Eli Lilly M&A, JP Morgan Healthcare, and a new high in the Nasdaq Biotech Index.
Hyundai robot complex keeps re-rating
Hyundai Motor Group's robot complex is re-rating around Boston Dynamics IPO expectations, governance restructuring, and robotics supply-chain roles at Hyundai Wia, Yujin Robot, Hyundai Glovis, Hyundai Mobis, and Hyundai AutoEver.
Korean defense underowned may be bought
US defense stocks were slow, but European defense was strong; Korean defense is likely under-owned and may be filled as FX and export momentum help results.
SK hynix ADR and target upside
SK hynix has an ADR disclosure expected around January 9, and Kiwoom raised its target to KRW 880,000 with 2026 operating profit of KRW 103 trillion; combined Samsung-SK profit estimates imply more market-cap upside.
Hyundai E&C wins US nuclear role
Hyundai E&C could benefit as the US Department of Energy names it in the SMR first-mover context, raising its chance to participate in US nuclear construction; target price was raised.
HD Korea Shipbuilding cheap LNG orders
HD Korea Shipbuilding & Offshore Engineering is the cheapest shipbuilding valuation, has a holding-company character, and should benefit from LNG orders; target was raised to KRW 600,000.
Iljin Electric leveraged to copper
Iljin Electric is attractive because copper prices are strong and its revenue mix is heavily skewed to cables, giving it higher leverage to power-infrastructure spending than transformer peers.
LS Electric costs cleared for 2026
LS Electric had a sharp correction, but restructuring costs are being cleared to set up 2026, and the direction is positive after a target upgrade.
Securities benefit from trading volume
Trading volume in large caps is exploding and brokerage target prices are being raised, making the securities sector momentum attractive.
Hanwha Aerospace defense space momentum
Hanwha Aerospace is moving on positive defense and space-related news and is part of the broader defense/space momentum.
L&F owner return turnaround
L&F is moving as owner management returns and the company disclosed the Tesla contract termination, raising expectations for a turnaround.
LNG orders lift shipbuilders
Shipbuilding is rebounding as LNG carrier orders come in and the sector recovers from a large decline.
Rare earth pressure lifts Union Materials
China's rare-earth pressure on Japan is lifting rare-earth-related stocks such as Union Materials.
Watch KOSDAQ policy support
KOSDAQ remains weak while KOSPI rises, and government activation measures for biotech and batteries are needed; if credible measures arrive, KOSDAQ could attract money.
Rocket Healthcare WGO partnership
Rocket Healthcare is strong after a strategic partnership with China's WGO Group for an AI hyper-personalized tissue-regeneration platform.
This 815 Money Talk (815머니톡) video, published January 08, 2026,
features Lee Kwon-hee, Ha Chang-bong, Lee Ju-hyeon, Min Jae-gi
discussing EWY, 307950.KS, 005380.KS, 086280.KS, 005930.KS, 000660.KS, 226950.KQ, 128940.KS, 249420.KS, 009420.KS, 097230.KS, Korean Biotech/Healthcare Sector, 034020.KS, 352820.KS, Korean Entertainment Sector, Korean shipbuilding sector, Korean defense sector, Korean nuclear power sector, 042700.KS, 034730.KS, 001040.KS, 006260.KS, 105560.KS, 006800.KS, 003670.KS, 066970.KS, Samsung semiconductor equipment suppliers, 058610.KQ, HVM, 035420.KS, 218410.KQ, WSI, MU, INTC, AMD, TSLA, LLY, 298380.KQ, 347850.KQ, GOOGL, KOSDAQ, NVDA, EUAD, ITA, 056080.KQ, 012330.KS, 204320.KS, 011210.KS, 047810.KS, Space/aerospace sector, DRIV, Korea Fuel-Tech, 068270.KS, Korean healthcare/biotech sector, 000720.KS, 009540.KS, 103590.KS, 010120.KS, 016360.KS, 012450.KS, 047400.KQ, 376900.KQ.
61 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Lee Kwon-hee,
Ha Chang-bong,
Lee Ju-hyeon,
Min Jae-gi
· Tickers:
EWY,
307950.KS,
005380.KS,
086280.KS,
005930.KS,
000660.KS,
226950.KQ,
128940.KS,
249420.KS,
009420.KS,
097230.KS,
Korean Biotech/Healthcare Sector,
034020.KS,
352820.KS,
Korean Entertainment Sector,
Korean shipbuilding sector,
Korean defense sector,
Korean nuclear power sector,
042700.KS,
034730.KS,
001040.KS,
006260.KS,
105560.KS,
006800.KS,
003670.KS,
066970.KS,
Samsung semiconductor equipment suppliers,
058610.KQ,
HVM,
035420.KS,
218410.KQ,
WSI,
MU,
INTC,
AMD,
TSLA,
LLY,
298380.KQ,
347850.KQ,
GOOGL,
KOSDAQ,
NVDA,
EUAD,
ITA,
056080.KQ,
012330.KS,
204320.KS,
011210.KS,
047810.KS,
Space/aerospace sector,
DRIV,
Korea Fuel-Tech,
068270.KS,
Korean healthcare/biotech sector,
000720.KS,
009540.KS,
103590.KS,
010120.KS,
016360.KS,
012450.KS,
047400.KQ,
376900.KQ
